Cutler Group LP Capricor Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 14, 2022	SELL	$2.83 - $5.68 $3,396 - $6,816	-1,200 Reduced 46.15%	1,400 $2,000
Q4 2021 Jan 18, 2022	SELL	$2.89 - $4.16 $1,734 - $2,496	-600 Reduced 18.75%	2,600 $2,000
Q3 2021 Oct 26, 2021	SELL	$3.8 - $5.23 $12,160 - $16,736	-3,200 Reduced 50.0%	3,200 $5,000
Q2 2021 Jul 19, 2021	BUY	$3.16 - $5.72 $13,904 - $25,168	4,400 Added 220.0%	6,400 $5,000
Q1 2021 Apr 26, 2021	SELL	$3.63 - $7.93 $82,038 - $179,218	-22,600 Reduced 91.87%	2,000 $3,000
Q4 2020 Jan 21, 2021	BUY	$3.43 - $5.23 $76,489 - $116,629	22,300 Added 969.57%	24,600 $8,000
Q3 2020 Oct 27, 2020	BUY	$4.08 - $9.81 $7,752 - $18,639	1,900 Added 475.0%	2,300 $1,000
Q2 2020 Jul 22, 2020	BUY	$1.0 - $8.5 $400 - $3,400	400 New	400 $0

8.13M

1.78M

1.4M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $440M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.